HIV/AIDS and blindness
Tags: BLINDNESS -- Risk factors; AIDS (Disease) -- Complications; CYTOMEGALOVIRUS infections
Related Articles
- Foscarnet administered by portable infusion device in AIDS patients with CMV infection. Bicart-See, Alain; Obadia, Martine // AIDS Patient Care & STDs;Apr97, Vol. 11 Issue 2, p76
Recommends the administration of foscarnet by portable infusion device in AIDS patients with cytomegalovirus (CMB) infection. Patients and methodology; Duration of treatment; Foscarnet maintenance therapy; Oral hydration.
- CMV Retinitis and the Controversies Associated with Highly Active Antiretroviral Therapy and the Immune Recovery Hypothesis. Reed, J. Brian; Morse, Lawrence S. // AIDS Patient Care & STDs;Mar1998, Vol. 12 Issue 3, p181
Examines controversy surrounding the role of highly active antiretroviral therapy (HAART) in cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS). Treatment of AIDS with HAART; Reference to studies showing the regression of CMV retinitis without anti-CMV...
- Natural History and Outcome of New AIDS-Related Cytomegalovirus Retinitis Diagnosed in the Era... Jacobson, Mark A.; Stanley, Hopkins; Holtzer, Christopher; Margolis, Todd P.; Cunningham, Emmett T. // Clinical Infectious Diseases;1/1/2000, Vol. 30 Issue 1, p231
Studies the history/outcome of acute immunodeficiency syndrome-related cytomegalovirus (CMV-R) retinitis in San Francisco, California, from 1994 through 1998 in patients who have received or will receive highly active antiretroviral therapy (HAART). Strong association of outcome for patients...
- A `breakthrough' on CMV drugs. // Ophthalmology Times;1/30/95, Vol. 20 Issue 5, p8
Reports that the United States Food and Drug Administration has approved the marketing of Cytovene, a ganciclovir capsule used for the treatment of cytomegalovirus (CMV) retinitis. Benefits to patients with AIDS; Comparison of intravenous (IV) and oral CMV medication trial studies; Marketability.
- Cytomegalovirus Hemorrhagic Gastritis. Ruiz Jr., Atenodoro R.; Borum, Marie L. // AIDS Patient Care & STDs;Jan2001, Vol. 15 Issue 1, p1
A 36-year-old male with acquired immune deficiency syndrome (AIDS) presented with intractable nausea and vomiting of 1 week's duration that was not attributable to his medications. An esophagogastroduodenoscopy showed hemorrhagic and necrotic gastric mucosa but no ulcers were found....
- Cytomegalovirus Esophagitis in Patients with AIDS. Wilcox, C. Mel; Diehl, David L.; Cello, John P.; Margaretten, William; Jacobson, Mark A. // Annals of Internal Medicine;10/15/90, Vol. 113 Issue 8, p589
Focuses on a study which examined the clinical presentation, endoscopic features, laboratory diagnosis, and outcome of cytomegalovirus esophagitis in patients with AIDS. Research design and setting; Characteristics of participating patients; Details of intervention; Measurements and results.
- Serious Cytomegalovirus Disease in the Acquired Immunodeficiency Syndrome (AIDS). Jacobson, Mark A.; Mills, John // Annals of Internal Medicine;Apr88, Vol. 108 Issue 4, p585
Focuses on cytomegalovirus infection in AIDS. Manifestations of several cytomegalovirus end-organ disease; Effectiveness of ganciclovir and foscarnet; Direction for clinical research in drug development.
- Editorial Response: Cytomegalovirus Retinitis in Persons with AIDS--A Shift in the Treatment... Polis, Michael A. // Clinical Infectious Diseases;3/1/99, Vol. 28 Issue 3, p534
Comments on research conducted by Mark A. Jacobson and colleagues on the treatment of cytomegalovirus (CMV) retinitis in persons with AIDS, published in the March 1999 issue of 'Clinical Infectious Diseases.' Progression of CMV in immunosuppressed patients; Use of antiretroviral agents to cure...
- Opportunistic Infections in Patients with and Patients without Acquired Immunodeficiency Syndrome. Sepkowitz, Kent A. // Clinical Infectious Diseases;4/15/2002, Vol. 34 Issue 8, p1098
In the next decade, longer survival of patients with cancer and more-aggressive therapies applied to common conditions, such as asthma and rheumatoid arthritis, will result in a larger population with significant immune system defects. Many in this population will be at risk for opportunistic...
